BorjeS.AnderssonMD

PubMed

• Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
  Sairah Ahmed, Qaiser Bashir, Roland L Bassett Jr, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa Khouri, David Marin, ...> ;American Journal of Hematology. 2024 Apr 1
• Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in high...
  Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand, Angela Granata, Samia Harbi, Raynier Devillier, Valerio Maisano, Benjamin Bouchacourt, Thomas Pagliardini, Djamel Moka...> ;Bone Marrow Transplantation. 2024 Mar 14
• ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells.
  Benigno C Valdez, Bin Yuan, David Murray, Jeremy L Ramdial, Uday Popat, Yago Nieto, Borje S Andersson> ;Oncotarget. 2024 Mar 14
• Autologous engineered T cell receptor therapy in advanced cancer.
  Baysal, M., Chakraborty, A., Tsimberidou, A., Andersson, B.> ;Human Vaccines & Immunotherapeutics. 2023 Dec 15
• 1 citations
  Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy.
  Yannick Bulliard, Borje S Andersson, Mehmet A Baysal, Jason Damiano, Apostolia M Tsimberidou> ;Journal of Hematology & Oncology. 2023 Oct 25
• 1 citations
  Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities.
  Uday R Popat, Oren Pasvolsky, Roland Bassett Jr, Rohtesh S Mehta, Amanda Olson, Julianne Chen, Amin M Alousi, Gheath Al-Atrash, Qaiser Bashir, Alison M Gulbis, Chitra ...> ;Blood Advances. 2023 Oct 24
• 1 citations
  High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
  Hanan Alkhaldi, Alec Reinhardt, Melissa Barnett, Suprateek Kundu, Chitra Hosing, Jeremy Ramdial, Neeraj Saini, Samer Srour, Amin Alousi, Partow Kebriaei, Uday Popat, M...> ;Transplantation and Cellular Therapy. 2023 Nov 1
• 5 citations
  Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
  Apostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson, Regina Mendrzyk, Amir Alpert, Claudia Wagner, Anna Nowak, Katrin Aslan, Arun Satelli, Fabian Richter, Sab...> ;Cancer Immunology Research. 2023 Jul 5
• Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells.
  Benigno C Valdez, Bin Yuan, David Murray, Jeremy Leon Ramdial, Yago Nieto, Uday Popat, Xiaowen Tang, Borje S Andersson> ;Frontiers in Oncology. 2023 Jan 1
• Effective T-cell replete haploidentical stem cell transplantation for pediatric patients with high-risk hematologic disorders.
  Supavich Tannumsaeung, Usanarat Anurathapan, Samart Pakakasama, Pongpak Pongpitcha, Duantida Songdej, Nongnuch Sirachainan, Borje S Andersson, Suradej Hongeng> ;European Journal of Haematology. 2023 Mar 1
• 4 citations
  HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their us...
  Benigno C Valdez, Yago Nieto, Bin Yuan, David Murray, Borje S Andersson> ;Oncotarget. 2022 Oct 14
• 1 citations
  Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells.
  Benigno C Valdez, Bin Yuan, David Murray, Yago Nieto, Uday Popat, Borje S Andersson> ;Leukemia & Lymphoma. 2022 Jul 1
• 2 citations
  A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase ...
  Uday R Popat, Borje S Andersson, Roland Bassett, Jitesh Kawedia, Ben C Valdez, Amin M Alousi, Gheath Al-Atrash, Qaiser Bashir, Chitra M Hosing, Jin S Im, Partow Kebria...> ;Haematologica. 2022 Oct 1
• 3 citations
  A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation.
  Borje S Andersson, Peter F Thall, Junsheng Ma, Benigno C Valdez, Roland Bassett Jr, Julianne Chen, Sairah Ahmed, Amin Alousi, Qaiser Bashir, Stefan Ciurea, Alison Gulb...> ;Bone Marrow Transplantation. 2022 Aug 1
• 5 citations
  Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leuk...
  Gheath Alatrash, Chantal Saberian, Roland Bassett, Peter F Thall, Celina Ledesma, Yoshimi Lu, May Daher, Benigno C Valdez, Jitesh Kawedia, Uday Popat, Rohtesh Mehta, B...> ;Transplantation and Cellular Therapy. 2022 Aug 1
• 1 citations
  Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia.
  Usanarat Anurathapan, Samart Pakakasama, Duantida Songdej, Pongpak Pongphitcha, Ampaiwan Chuansumrit, Borje S Andersson, Suradej Hongeng> ;Hemoglobin. 2022 Jan 1
• 5 citations
  ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells.
  Benigno C Valdez, David Murray, Bin Yuan, Yago Nieto, Uday Popat, Borje S Andersson> ;Oncotarget. 2022 Jan 1
• 6 citations
  Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical Trial.
  Rohtesh S. Mehta, Roland L. Bassett, Julianne Chen, Benigno C. Valdez, Jitesh D. Kawedia, Amin M. Alousi, Paolo Anderlini, Gheath Alatrash, Qaiser Bashir, Stefan O. Ci...> ;Transplantation and Cellular Therapy. 2021 Nov 1
• 49 citations
  T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors.
  Apostolia Maria Tsimberidou, Karlyle Van Morris, Henry Hiep Vo, Stephen Eck, Yu Feng Lin, Jorge Mauricio Rivas, Borje S. Andersson> ;Journal of Hematology & Oncology. 2021 Jun 30
• 8 citations
  Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Haematologica. 2021 May 6
• 2 citations
  Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma.
  Jacinth Joseph, Junsheng Ma, Fady Hennawy, Mustafa Nooruldeen Abdulrazzaq, Neeraj Saini, Romil Patel, Chitra Hosing, Amin M. Alousi, Paolo Anderlini, Uday R. Popat, Mu...> ;Transplantation and Cellular Therapy. 2021 May 1
• 14 citations
  Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial.
  Sairah Ahmed, Qaiser Bashir, Roland L. Bassett, Man Yin C. Poon, Ben C. Valdez, Sergej Konoplev, Amin M. Alousi, Borje S. Andersson, Stefan O. Ciurea, Chitra Hosing, R...> ;Transplantation and Cellular Therapy. 2021 May 1
• 19 citations
  Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation.
  Amanda Olson, Ruitao Lin, David Marin, Hind Rafei, Mustafa Bdaiwi, Peter F. Thall, Rafet Basar, Ala Abudayyeh, Pinaki P. Banerjee, Fleur M. Aung, Indresh Kaur, Glorett...> ;Journal of Clinical Oncology. 2021 Apr 30
• 9 citations
  Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality
  Jeremy Ramdial, Rohtesh S. Mehta, Rima M. Saliba, Amin M. Alousi, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Amanda Olson, Betul Oran, Muzaffar H. Qazilbash, Samer...> ;Bone Marrow Transplantation. 2021 Apr 12
• 14 citations
  Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cel...
  Xiaowen Tang, Benigno C. Valdez, Yunju Ma, Qianqian Zhang, Changju Qu, Haiping Dai, Jia Yin, Zheng Li, Ting Xu, Yang Xu, Jia Chen, Xiaming Zhu, Zi-Xing Chen, Depei Wu,...> ;Bone Marrow Transplantation. 2021 Feb 26
• Join now to see all

Journal Articles

• Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...  
  Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature

Abstracts/Posters

• Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Decitabine As Part of a Modified Bu-Cy Conditioning Regimen Significantly Improved the Outcome of High-Risk AML Patients Undergoing Allogeneic Hematopoietic Stem Cell ...
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Hematopoietic Cell Transplant -Composite Risk (HCT-CR) - a Novel Prognostic Model to Predict Transplant Outcomes 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018